Viral vector manufacturing - 1 News by Merck

Viral vector manufacturing - 1 News by Merck

image description

Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering

Advances Merck’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing

06-Aug-2024 - Merck announced the closing of the transaction to acquire Mirus Bio for approximately US$600million (around €550million), following regulatory clearances and the fulfillment of other customary closing conditions. The acquisition is a strategic step towards Merck's ambition to offer solutions ...

viral vector manufacturing life science takeovers

These products might interest you

Large capcity CellXpert® CS220 CO2 Incubator Shaker New

Large capcity CellXpert® CS220 CO2 Incubator Shaker by Eppendorf

First CO₂ Incubator Shaker with Integrated 180°C Sterilization

Maximize capacity and safety for your mammalian shake flask cultures

CO2 incubators
View product
Show all viral vector manufacturing
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 27,240 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now